Linagliptin Indications Diajenta is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults. Pharmacology Linagliptin is indicated to improve glycemic control in patients with type 2 diabetes mellitus. Linagliptin is an inhibitor of DPP-4 (dipeptidyl peptidase-4), an enzyme that degrades the incretin hormones GLP-1 (glucagon like peptide-1) and GIP […]